Ardelyx (ARDX) FCF Margin (2013 - 2026)

Ardelyx (ARDX) reported FCF Margin of 34.2% for Q1 2026, up 1813.0% on a YoY basis from 1.79% in Q1 2025, and down 307.96% quarter-over-quarter from 16.44% in Q4 2025.

Ardelyx (ARDX) FCF Margin (2013 - 2026) Analysis & Trends

Ardelyx has reported FCF Margin for 12 years, with the latest figure at 34.2% in Q1 2026.

  • For the quarter ending Q1 2026, FCF Margin rose 1813.0% year-over-year to 34.2%; the trailing twelve-month figure through Mar 2026 stood at 11.69% (up 178.0% YoY), and the FY2025 full-year result was 10.8%, up 294.0% from the prior year.
  • FCF Margin for Q1 2026 stood at 34.2%, down from 16.44% in the prior quarter.
  • The five-year high for FCF Margin was 32.21% in Q4 2022, with the low at 5901.71% in Q1 2022.
  • Historically, FCF Margin has averaged 489.95% across 5 years, with a median of 34.2% in 2026.
  • Annual changes were most pronounced in 2022 — FCF Margin plunged 521810 bps — and 2023, when it soared 550758 bps.
  • Ardelyx's FCF Margin stood at 32.21% in 2022, then slumped by 179 bps to 25.5% in 2023, then soared by 131 bps to 7.94% in 2024, then soared by 107 bps to 16.44% in 2025, then sank by 308 bps to 34.2% in 2026.
  • The last three FCF Margin figures came in at 34.2% (Q1 2026), 16.44% (Q4 2025), and 6.15% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -3.98%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 43.35%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Ardelyx 1.49 Bn 1.25 Bn 89.66 Mn -34.20%

Historic Data

Download Data
DateValue
Mar 31, 2026 -34.20%
Dec 31, 2025 16.44%
Sep 30, 2025 6.15%
Jun 30, 2025 -26.61%
Mar 31, 2025 -52.33%
Dec 31, 2024 7.94%
Sep 30, 2024 0.37%
Jun 30, 2024 -26.67%
Mar 31, 2024 -77.94%
Dec 31, 2023 -25.50%
Sep 30, 2023 -38.41%
Jun 30, 2023 -66.40%
Mar 31, 2023 -394.13%
Dec 31, 2022 32.21%
Sep 30, 2022 -509.97%
Jun 30, 2022 -1,238.36%
Mar 31, 2022 -5,901.71%
Dec 31, 2021 -3,826.43%
Sep 30, 2021 -2,986.70%
Jun 30, 2021 -2,666.79%